image
Larimar Therapeutics, Inc. LRMR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.69
-11.6 %
$ 427 M
Market Cap
-5.82
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% -8.09% -14.32%
Annual Report FY 10-K 2022-12-31 0.00% 32.05% 27.62%
Annual Report FY 10-K 2021-12-31 0.00% -18.86% -17.90%
Annual Report FY 10-K 2020-12-31 0.00% -82.98% -84.39%
Annual Report FY 10-K 2019-12-31 0.00% 62.31% 62.99%
Annual Report FY 10-K 2018-12-31 0.00% -17.95% -16.42%
Annual Report FY 10-K 2017-12-31 0.00% 10.11% 5.68%
Annual Report FY 10-K 2016-12-31 0.00% 22.09% 22.61%
Annual Report FY 10-K 2015-12-31 0.00% -103.13% -107.74%
Annual Report FY 10-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -71.00% -76.65%
Quarterly Report Q2 8-K 2024-06-30 0.00% -158.51% -155.71%
Quarterly Report Q1 8-K 2024-03-31 0.00% -170.62% -119.12%
Quarterly Report Q4 8-K 2023-12-31 0.00% -54.48% -35.66%
Quarterly Report Q3 8-K 2023-09-30 0.00% -11.53% -21.45%
Quarterly Report Q2 8-K 2023-06-30 0.00% 3.25% -10.74%
Quarterly Report Q1 8-K 2023-03-31 0.00% 39.83% 14.07%
Quarterly Report Q4 8-K 2022-12-31 0.00% 7.92% -14.89%
Quarterly Report Q3 8-K 2022-09-30 0.00% 51.64% 49.12%
Quarterly Report Q2 8-K 2022-06-30 0.00% 31.42% 30.74%
Quarterly Report Q1 8-K 2022-03-31 0.00% 25.55% 26.59%
Quarterly Report Q4 8-K 2021-12-31 0.00% 35.69% 36.88%
Quarterly Report Q3 8-K 2021-09-30 0.00% -63.57% -61.88%
Quarterly Report Q2 8-K 2021-06-30 0.00% -11.29% -10.04%
Quarterly Report Q1 8-K 2021-03-31 0.00% -81.12% -81.39%
Quarterly Report Q4 8-K 2020-12-31 0.00% -133.76% -133.76%
Quarterly Report Q3 8-K 2020-09-30 0.00% -19.08% -19.78%
Quarterly Report Q2 8-K 2020-06-30 0.00% -205.89% -207.75%
Quarterly Report Q1 8-K 2020-03-31 0.00% -141178.58% -141178.58%
Quarterly Report Q4 8-K 2019-12-31 0.00% 58.30% 58.08%
Quarterly Report Q3 8-K 2019-09-30 0.00% 42.74% 43.12%
Quarterly Report Q2 8-K 2019-06-30 0.00% 76.52% 76.20%
Quarterly Report Q1 8-K 2019-03-31 0.00% 99.97% 99.97%
Quarterly Report Q4 8-K 2018-12-31 0.00% -11.35% -9.98%
Quarterly Report Q3 8-K 2018-09-30 0.00% -19.72% -18.14%
Quarterly Report Q2 8-K 2018-06-30 0.00% -18.19% -14.95%
Quarterly Report Q1 8-K 2018-03-31 0.00% -22.63% -18.37%
Quarterly Report Q4 8-K 2017-12-31 0.00% -25.35% -27.52%
Quarterly Report Q3 8-K 2017-09-30 0.00% 14.24% 13.42%
Quarterly Report Q2 8-K 2017-06-30 0.00% 11.19% 10.13%
Quarterly Report Q1 8-K 2017-03-31 0.00% 26.64% 25.72%
Quarterly Report Q4 8-K 2016-12-31 0.00% 54.95% 54.94%
Quarterly Report Q3 8-K 2016-09-30 0.00% 26.20% 24.78%
Quarterly Report Q2 8-K 2016-06-30 0.00% 15.36% 14.47%
Quarterly Report Q1 8-K 2016-03-31 0.00% -31.65% -34.87%
Quarterly Report Q4 8-K 2015-12-31 0.00% -57.76% -61.87%
Quarterly Report Q3 8-K 2015-09-30 0.00% -208.61% -229.39%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%